SGLT2i cuts cardiovascular, renal risk in diabetics
Compared with dipeptidyl peptidase-four inhibitors (DPP4i), using sodium glucose co-transporter 2 inhibitors (SGLT2i) is related to decrease danger of cardiovascular…
Compared with dipeptidyl peptidase-four inhibitors (DPP4i), using sodium glucose co-transporter 2 inhibitors (SGLT2i) is related to decrease danger of cardiovascular…